Mein Warenkorb

HLA-A*0201 & B2M & HER2 (LIAHNQVRQV)

HLA-A*0201 & B2M & HER2 (LIAHNQVRQV) Produktliste

  • Attribut

    Protein (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    Human (1)

  • Etikett

    His Tag & Avi Tag (1)

  • Marker

    Biotin-labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
HL2-H82E3
Human
HEK293
Biotinylated Human HLA-A*02:01&B2M&HER2 (LIAHNQVRQV) Complex Protein (Monomer, MALS verified) In den Warenkorb legen
Gesamtmenge1
  • 1

HLA-A*0201 & B2M & HER2 (LIAHNQVRQV) Molekülhintergrund

Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation. The Human HLA-A*0201 HER2 (LIAHNQVRQV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M and LIAHNQVRQV peptide of the HER2.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
NC-318NC-318; 5G-12Phase 2 ClinicalYale School Of MedicineSolid tumours; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Cholangiocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma
Details
DS-1501DS-1501Phase 1 ClinicalDaiichi Sankyo Co LtdOsteoporosis
Details
PYX-106PYX-106; BSI-060TPhase 1 ClinicalBoaoxin Biotechnology(Nanjing) Co LtdSolid tumours; Neoplasm Metastasis
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns